Journal of the American Pharmacists Association : JAPhA
-
J Am Pharm Assoc (2003) · Sep 2010
ReviewRole of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
To review the available literature on the effects of angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers (ARBs), and calcium channel blockers (CCBs) or combinations of these agents on stroke outcomes in hypertensive patients. ⋯ A growing body of clinical trial data suggest that aggressive combination antihypertensive therapy, including a RAAS blocker and CCB, may help reduce stroke incidence. Fixed-dose combination therapy is an important consideration in optimizing blood pressure control and patient adherence to therapy in stroke prevention.
-
To provide pharmacists with a current, comprehensive review of medication adherence challenges and solutions. ⋯ Nonadherence to a medication regimen may have multiple underlying causes, some of which may be easier to address than others. Open discussion between the pharmacist and patient regarding barriers to adequate medication adherence, followed by a multifaceted, personalized intervention to address these barriers, plays a key role in encouraging patients to adhere to the recommendations of the health care team.
-
J Am Pharm Assoc (2003) · Sep 2009
ReviewHealth literacy: a barrier to pharmacist-patient communication and medication adherence.
To present a summary of the existing literature on medication nonadherence, health literacy, and use of written patient information in health care and pharmacy in particular. ⋯ The health literacy skills of American adults have not changed considerably during the previous decade. This makes use of written patient medication information in pharmacy practice problematic for some patients. Limited health literacy has been associated with poorer health, medication nonadherence, medication errors, higher medical expenses, and increased hospitalization. A need exists for identifying patients with limited health literacy and tailoring medication counseling to their needs.
-
J Am Pharm Assoc (2003) · Sep 2009
ReviewPharmacist roles in the management of patients with type 2 diabetes.
To summarize the current and future roles of pharmacists in providing care to and educating patients with diabetes. ⋯ With the increasing complexity of therapy regimens and overwhelming numbers of patients with type 2 diabetes, the pharmacist's role has expanded beyond dispensing medications, counseling on adverse effects, and monitoring for contraindications to include evaluation and initiation of new agents to optimize patient outcomes.
-
J Am Pharm Assoc (2003) · May 2009
ReviewIntegration of temperature-controlled requirements into pharmacy practice.
To describe (a) Food and Drug Administration (FDA) regulations and guidelines issued by several professional organizations to ensure appropriate storage, handling, and distribution of temperature-controlled prescription drugs from manufacturer to wholesaler to pharmacy to patients; (b) pharmacy business practices that ensure the dispensing of high-quality temperature-controlled drug products; and (c) education that facilitates patients' important role in maintaining product quality. ⋯ The transit, handling, and storage of temperature-controlled drug products within complex supply chains provide opportunities for exposure of such drugs to temperatures above or below those recommended by the manufacturer. Pharmacists have opportunities to integrate business practices that facilitate the proper receipt, handling, and storage of temperature-controlled drug products. These practices will enhance the dispensing of high-quality, efficacious drug products to patients and proper handling and storage by patients.